Why did Peter Thiel cut his Tesla stake?
How will Trump’s tariff rollbacks impact inflation?
What caused Nvidia stock to wobble recently?
Why is the FAA lifting flight restrictions now?
How did Amazon’s $12B bond sale affect markets?
What’s behind DoorDash’s $18M Chicago settlement?
Why is Bitcoin hitting six-month lows again?
Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout
benzinga.com/m-a/25/11/48836647/day-one-biopharma-expands-oncology-pipeline-with-285-million-mersana-buyout
Day One Biopharmaceuticals (NASDAQ:DAWN) on Thursday agreed to acquire Mersana Therapeutics Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers.
DAWN is among today’s weakest performers. Get the…
This story appeared on benzinga.com, 2025-11-13 15:15:16.